Acepix Biosciences

Executive Summary

Acepix Biosciences is a life science research tools and services company headquartered in Cambridge, Massachusetts, specializing in high-quality biospecimens and histopathology services. Founded in 2015, the company focuses on providing FFPE cell pellets, tissue arrays, and related services to support biomarker discovery, assay validation, and translational research in oncology and immunology. By offering standardized, well-characterized materials and expert histopathology support, Acepix enables pharmaceutical and biotech partners to accelerate preclinical and diagnostic development. The company operates in the growing precision medicine market, where demand for reliable biospecimens and contract research services continues to rise. Although Acepix is privately held and pre-clinical stage, its role as a service provider positions it to benefit from increased R&D outsourcing by drug developers.

Upcoming Catalysts (preview)

• Q3 2026Major pharma partnership for oncology tissue array supply60% success
• Q4 2026Launch of expanded FFPE cell pellet product line targeting rare tumor types70% success
• Q2 2026Announcement of new histopathology service contracts with top-20 biotech firms50% success